Skip to main content
Log in

Experimental Determination and Theoretical Calculation of the Eutectic Composition of Cefuroxime Axetil Diastereomers

  • Research Article
  • Published:
AAPS PharmSciTech Aims and scope Submit manuscript

Abstract

Cefuroxime axetil (CFA), an ester prodrug of cefuroxime exists as a pair of diastereoemers, namely isomer A and isomer B. To enable phase diagram construction, crystallization of the diastereomers of CFA from the commercially available amorphous drug substance was carried out. Isomer A was separated with a purity approaching 100% whereas the maximum purity of isomer B was 85% as confirmed by solution state proton NMR spectroscopy. The crystalline forms of isomer A and isomer B were confirmed as forms AI and BI, respectively, based on differential scanning calorimetry (DSC) analysis and powder X-ray diffraction. DSC analysis was used to observe the melting behavior of different diastereomer mixture compositions. The binary solid-liquid phase diagram for mixture compositions ranging from 0 to 85% w/w isomer B indicated the formation of a eutectic mixture having a melting temperature of 124.7 ± 0.4°C and a composition of 75% w/w (+/−5% wt.) isomer B. The eutectic composition was calculated using an index based on the van’t Hoff equation for melting point depression and was found to be 75% isomer B and 25% isomer A. As CFA is present in commercial preparations as a mixture of diastereomers, the formation of a eutectic mixture between the diastereomers may impact the solubility and stability of the commercial product. Eutectic formation can be explained on the basis of the chemical similarity of diastereomers that favor miscibility in the liquid state.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Kees F, Lukassek U, Naber KG, Grobecker H. Comparative investigation on the bioavailability of cefuroxime axetil. Drug Res. 1991;41:843–6.

    CAS  Google Scholar 

  2. Mosher GL, McBee J, Shaw DB. Esterase activity towards diastereomers of cefuroxime axetil in the rat and dog. Pharm Res. 1992;9:687–9.

    Article  CAS  PubMed  Google Scholar 

  3. Stoeckel K, Hofheinz W, Laneury JP, Duchene P, Shedlofsky S, Blouin RA. Stability of cephalosporin prodrug esters in human intestinal juice: implications for oral bioavailability. Antimicrob Agents Chemother. 1998;42:2602–6.

    CAS  PubMed  PubMed Central  Google Scholar 

  4. Osczapowicz I, Malafiej E, Horoszewicz-Malafiej A, Szelachowska M, Kuklewicz C, Sieranska E. Esters of cephalosporins. Part III. Separation and properties of the R and S isomers of 1-acetoxyethyl ester of cefuroxime. Acta Pol Pharm. 1995;52:471–6.

    Google Scholar 

  5. Park A, Chyall LJ, Byrn S. Characterization of cefuroxime axetil. Glaxo Wellcome, SR-5597.01, SSCI Inc. 2000; West Lafayette, Indiana.

  6. Li ZJ, Grant DJW. Relationship between the physical properties and crystal structures of chiral drugs. J Pharm Sci. 1997;86:1073–8.

    Article  CAS  PubMed  Google Scholar 

  7. Law D, Wang W, Schmitt EA, Long MA. Prediction of poly(ethylene) glycol-drug eutectic compositions using an index based on the van’t Hoff equation. Pharm Res. 2002;19:315–21.

    Article  CAS  PubMed  Google Scholar 

  8. Furuyama N, Hasegawa S, Yada S, Hamaura T, Wakiyama N, Yonemochi E, et al. Do amorphous troglitazone prepared from two diastereomer-pairs have the same molecular mobility and crystallization rate at the surface? Chem Pharm Bull. 2011;59(12):1452–7.

    Article  CAS  PubMed  Google Scholar 

  9. Bhatnagar BS, Cardon S, Pikal MJ, Bogner RH. Reliable determination of freeze-concentration using DSC. Thermochim Acta. 2005;425:149–63.

    Article  CAS  Google Scholar 

  10. Kansal VK, Bhat SG. An improved method for preparation of cefuroxime axetil. 2004. EP 1 409 492 B1.

  11. Mosher GL, Mullen MV. R-Cefuroxime axetil. 1991. U.S. Patent 5,063,224.

  12. Bi M, Hwang S-J, Morris KR. Mechanism of eutectic formation upon compaction and its effect on tablet properties. Thermochim Acta. 2003;404:213–26.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The authors would like to thank the Mylan School of Pharmacy and the Duquesne University Faculty Development Fund (FDF) for providing financial support for this work. They would also like to thank Dhanuka Laboratories, Mumbai for donating the cefuroxime axetil used for this work.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ira S. Buckner.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dalal, N., Buckner, I.S. & Wildfong, P.L.D. Experimental Determination and Theoretical Calculation of the Eutectic Composition of Cefuroxime Axetil Diastereomers. AAPS PharmSciTech 18, 2570–2578 (2017). https://doi.org/10.1208/s12249-017-0739-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1208/s12249-017-0739-8

KEY WORDS

Navigation